Sidedness matters for metastatic disease, and right-sided colon cancer has been known for a shorter time than left-sided colon cancer, making the right-sided version more difficult to treat, explained Alan Venook, MD, of the University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center.
Sidedness matters for metastatic disease, and right-sided colon cancer has been known for a shorter time than left-sided colon cancer, making the right-sided version more difficult to treat, explained Alan Venook, MD, of the University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center.
Transcript
Why is right-sided colon cancer such a challenging disease to treat compared with left-sided disease?
First of all, we’ve only known about this for a little while. We should have known about it a long time ago; but it turns out that the sidedness matters for metastatic disease, not for stage 1, 2, or 3, at least the best we can tell. It may be that the right side is just a different disease because it comes from a different part of the embryo. The right colon comes from the mid gut, the left colon from the hind gut, and the transverse colon is where they merge in embryogenesis. There may be some mild molecular differences, a tendency for BRAC mutations to be on the right side. Our working hypothesis right now is more that it’s got to do with its biome, the microbiome which may either impact the biology of the cancer or the impact of the immune system on the cancer. So, we’re not exactly sure but we think the biome may be responsible.
Some of this is fed by the recent observations—the amazing observations that you can find bacterial DNA in tumor metastases. Let’s say you take a biopsy of a patient with liver metastases. When we do next [generation] sequencing looking for the genetic mutations, we throw away a lot of DNA which doesn’t make sense. Turns out, some of that may be bacterial DNA, and what is that doing there and if it’s there, is it there for a reason? We see it in colon cancer liver metastases, we see it in colon cancer liver metastases, we see it in pancreas cancer liver metastases—maybe we’d see it everywhere if we looked. That’s the mystery. I think that’s the most exciting thing in terms of the challenge of figuring out just what the biome is and what we can do about it, but that may account for the sidedness.
Regenerating Neurons, Muscle, and Hope in the Field of Muscular Dystrophy
March 13th 2025The 2025 Muscular Dystrophy Association Clinical & Scientific Conference, convening in Dallas, Texas, from March 16-18, will feature clinical updates, expert insights, and breaking trial findings that sum up to a new frontier of care for neuromuscular diseases.
Read More
Addressing Financial Aid and Patient Independence as Part of Atopic Dermatitis Care
March 13th 2025Discussions centered on mitigating the financial burden of pediatric atopic dermatitis through financial aid programs and enhancing support for young patients to independently manage their condition were emphasized at this year’s 2025 American Academy of Dermatology meeting.
Read More
Late-Breaking Antiviral Session Features Phase 3 Results on Efficacy of Doravirine/Islatravir
March 13th 2025The combination of doravirine plus islatravir was noninferior to bictegravir/emtricitabine/tenofovir alafenamide and oral antiretroviral therapy in patients who switched to doravirine plus islatravir.
Read More